NFKB1 and breast carcinoma: Compared to the wild-type controls, the KO mice had significantly lower mammary tumor-free survival and exhibited rapid, aggressive mammary carcinoma progression with concomitant increase (2-fold) in NF-κB activation in mammary carcinomas.